Epigral Q4 Results
- BSE: 543332
- NSE: EPIGRAL
- ISIN: INE071N01016
- Sector: Chemical Manufacturing
BSE
989.90
-13.95 (-1.39%)
-13.95 (-1.39%)Volume1.30 K
Updated: Fri 6 Feb, 2026 | 15:26:25
NSE
992.50-10.50 (-1.05%)
-10.50 (-1.05%)Volume42.92 K
Updated: Fri 6 Feb, 2026 | 15:25:29
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Epigral Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 488.20 | 537.13 | -1.50% | 399.67 | 22.15% |
| Depreciation/ Amortization | 33.95 | 42.75 | 3.16% | 30.38 | 11.77% |
| Operating Income | 139.43 | 59.99 | -6.80% | 124.97 | 11.57% |
| Net Income | 86.89 | 39.11 | -16.15% | 77.28 | 12.44% |
| Other Operating Expenses Total | 56.63 | 62.27 | -19.23% | 49.02 | 15.52% |
| Net Income Before Taxes | 131.33 | 54.56 | -14.51% | 113.46 | 15.75% |
| Total Revenue | 627.63 | 597.12 | -2.73% | 524.63 | 19.63% |
| Selling/ General/ Admin Expenses Total | 31.00 | 31.61 | 6.57% | 25.52 | 21.47% |
| Diluted Normalized EPS | 20.16 | 9.07 | -16.87% | 18.60 | 8.39% |